A group is advocating for more federal money for states like Florida to boost their newborn screening for rare diseases to keep more children alive.

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the U.S. Food and ...